PMC:7283670 / 79920-80165 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T434","span":{"begin":218,"end":221},"obj":"Disease"}],"attributes":[{"id":"A434","pred":"mondo_id","subj":"T434","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"}],"text":"Phase I clinical trial in healthy adult Biological: recombinant novel coronavirus vaccine (adenovirus type 5 vector) – 108, all, 18–60 Prevention Experimental: low‐dose group subjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T669","span":{"begin":132,"end":134},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T670","span":{"begin":230,"end":232},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"Phase I clinical trial in healthy adult Biological: recombinant novel coronavirus vaccine (adenovirus type 5 vector) – 108, all, 18–60 Prevention Experimental: low‐dose group subjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T318","span":{"begin":174,"end":179},"obj":"Chemical"}],"attributes":[{"id":"A318","pred":"chebi_id","subj":"T318","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Phase I clinical trial in healthy adult Biological: recombinant novel coronavirus vaccine (adenovirus type 5 vector) – 108, all, 18–60 Prevention Experimental: low‐dose group subjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old"}

{"project":"LitCovid-sentences","denotations":[{"id":"T703","span":{"begin":0,"end":245},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Phase I clinical trial in healthy adult Biological: recombinant novel coronavirus vaccine (adenovirus type 5 vector) – 108, all, 18–60 Prevention Experimental: low‐dose group subjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1939","span":{"begin":65,"end":82},"obj":"Species"},{"id":"1940","span":{"begin":92,"end":109},"obj":"Species"},{"id":"1941","span":{"begin":222,"end":226},"obj":"Species"}],"attributes":[{"id":"A1939","pred":"tao:has_database_id","subj":"1939","obj":"Tax:2697049"},{"id":"A1940","pred":"tao:has_database_id","subj":"1940","obj":"Tax:28285"},{"id":"A1941","pred":"tao:has_database_id","subj":"1941","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Phase I clinical trial in healthy adult Biological: recombinant novel coronavirus vaccine (adenovirus type 5 vector) – 108, all, 18–60 Prevention Experimental: low‐dose group subjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old"}